Concepedia

Hiroyuki Moritomo

HM

Statistics

Publications

7

Citations

432

H-Index

7

Active since

1996

Affiliations

Astellas Pharma (Japan)(Current)

Ludwig Cancer Research

Cancer Research UK

Institute of Cancer Research

The Honourable Society of Lincoln's Inn

Hiroyuki Moritomo is an author at Astellas Pharma (Japan) specializing in medicinal chemistry, pharmacy, and pharmacology.

Publications per year

1996–2022

7

Publications

7

Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110α inhibitors

Masahiko Hayakawa, Hiroyuki Kaizawa, Hiroyuki Moritomo et al. · Bioorganic & Medicinal Chemistry · 2006 · 195 citations

, , +11

Synthesis and biological evaluation of pyrido[3′,2′:4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110α inhibitors

Masahiko Hayakawa, Hiroyuki Kaizawa, Hiroyuki Moritomo et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 141 citations · Full text

, , +12

Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2

Ikumi Kuriwaki, Minoru Kameda, Hiroyuki Hisamichi et al. · Bioorganic & Medicinal Chemistry · 2020 · 37 citations · Full text

, , +17

Construction of three types of fused isoindoles via furan-pyrrole ring exchange reaction

Mase Lee, Hiroyuki Moritomo, Ken Kanematsu · Tetrahedron · 1996 · 17 citations

, , +10

Identification of 4-benzylamino-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5-carboxamide derivatives as potent and orally bioavailable STAT6 inhibitors

S. Nagashima, Hiroshi Nagata, Masahiro Iwata et al. · Bioorganic & Medicinal Chemistry · 2008 · 16 citations · Full text

, , +11

1–5 of 7